Trusted by 100,000+ International Patients
Kidney Cancer Treatment: Italy vs Malaysia
Cost, Quality & Recovery Compared
$16000
Italy Starting Cost
$35000
Malaysia Starting Cost
See how these top medical tourism destinations compare for Kidney Cancer Treatment.
| Comparison Factor | Italy | Malaysia | Winner |
|---|---|---|---|
| Average Cost (in USD) | 16000 - 32000 | 35000 - 75000 | Italy |
| Success Rate (Min and Max) | 70% – 90% | 75% – 92% | Malaysia |
| Advanced Technology | Robotic and laparoscopic nephrectomy, PET-CT imaging, advanced CT/MRI diagnostics, targeted therapy, and immunotherapy available in specialised oncology centres. | Robotic and laparoscopic nephrectomy, high-resolution CT/MRI imaging, PET-CT, targeted therapy, and immunotherapy are available in leading oncology centres. | Both Equal |
| JCI Accredited Hospitals | 15+ | 10+ | Italy |
| Visa Process | Schengen Medical Visa | Medical Visa / eVisa / Tourist Visa (3–5 working days) | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Italy and Malaysia maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Hospitals in Italy operate under European Union healthcare regulations and the Italian National Health Service (Servizio Sanitario Nazionale – SSN), ensuring strict quality and patient safety standards.
High-volume cancer centres follow international oncology guidelines such as EAU and NCCN. Treatment outcomes vary based on tumour stage, patient health, and treatment strategy.
Cancer treatment in Italy is regulated under national healthcare authorities and EU clinical standards, ensuring evidence-based oncology protocols and modern diagnostic infrastructure.
Many hospitals in Malaysia are accredited by the Joint Commission International (JCI) and the Malaysian Society for Quality in Health (MSQH), ensuring high standards of oncology care.
Cancer centres follow international oncology guidelines (NCCN, EAU), with outcomes depending on tumour stage, surgical technique, and systemic therapy.
Healthcare services are regulated by the Malaysian Ministry of Health (MOH), ensuring strict clinical safety, oncology protocols, and quality standards.
| Quality Metric | Italy | Malaysia |
|---|---|---|
Accredited Hospitals | 15+ | 10+ |
Minimally Invasive Nephrectomy Availability | Yes (major tertiary hospitals) | Yes (major tertiary hospitals) |
Top Speciality Hospital Hubs | Rome, Milan, Bologna, Florence | Kuala Lumpur, Penang, Johor Bahru |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Uro-oncology surgeons
Experienced surgical teams performing robotic and minimally invasive nephrectomy procedures in specialised cancer and urology centres.
Uro-oncology surgeons
Moderate to high volume
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Leading Italian hospitals provide advanced oncology infrastructure including robotic surgery systems, high-resolution CT/MRI scanners, PET-CT imaging, modern operating theatres, oncology ICUs, and specialised pathology laboratories supporting precision cancer diagnosis and treatment planning.
Luxury healthcare experience
Leading Malaysian hospitals offer advanced oncology infrastructure including robotic-assisted surgery (Da Vinci systems), modern operating theatres, PET-CT scanners, high-resolution CT/MRI imaging, dedicated oncology ICUs, and advanced pathology labs for precise diagnosis and personalised cancer treatment planning.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after Kidney Cancer Treatment in both countries.
Kidney cancer treatment typically involves partial or radical nephrectomy, depending on tumour size and stage.
Patients may spend a short period in the ICU for post-operative monitoring after surgery.
A short stay in Italy allows doctors to monitor recovery, wound healing, and kidney function before travel.
Patients gradually resume normal activities with regular follow-up and imaging surveillance.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
Kidney cancer treatment typically involves partial or radical nephrectomy depending on tumour characteristics.
Patients may require short ICU monitoring post-surgery.
International patients are advised to stay locally for early recovery and follow-up imaging.
Recovery improves gradually with regular monitoring and lifestyle adjustments.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
Kidney Cancer Treatment recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your Kidney Cancer Treatment journey.
Surgery may carry risks of bleeding or infection at the surgical site.
Removal of a kidney may affect overall kidney function, requiring monitoring.
Patients may experience temporary pain, swelling, or fatigue during recovery.
Complications such as blood clots or urinary issues may occur in rare cases.
Targeted therapy or immunotherapy may cause fatigue, blood pressure changes, or immune-related effects.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Patients diagnosed with kidney cancer require tumour removal or kidney removal surgery. Some patients may require additional therapies such as targeted therapy, immunotherapy, or precision oncology, depending on disease stage and clinical evaluation.
Patients diagnosed with kidney cancer requiring tumour removal (partial or radical nephrectomy), with possible need for targeted therapy or immunotherapy based on cancer stage and progression.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your Kidney Cancer Treatment journey.
Consult a uro-oncologist to confirm diagnosis and stage through CT scans, MRI, and pathology reports.
Doctors evaluate whether partial nephrectomy or radical nephrectomy is the best surgical option.
Plan a comprehensive budget including surgery, hospital stay, medications, and possible targeted therapy.
Provide prior imaging scans, biopsy reports, and treatment records for accurate planning.
Regular follow-up imaging and blood tests are necessary to monitor recovery and detect recurrence early.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
